Recently, in the Best Practices Case Creation Activity for the Board of Directors of Listed Companies in 2024 organized by the China Association of Listed Companies, Eyebright Medical Technology (Beijing) Co., Ltd. was awarded the Outstanding Practice Case of the Board of Directors of Listed Companies in 2024. The company adheres to compliant operations and high-standard information disclosure, achieving the highest grade A level in the information disclosure evaluation of listed companies on the Shanghai Stock Exchange for two consecutive years; through multi-channel and multi-format communication, it enhances interaction and communication with investors, increasing market recognition of the company's intrinsic value.